Literature DB >> 1602395

Plasma dopa responses during stress: dependence on sympathoneural activity and tyrosine hydroxylation.

R Kvetnansky1, I Armando, V K Weise, C Holmes, K Fukuhara, A Deka-Starosta, I J Kopin, D S Goldstein.   

Abstract

Dihydroxyphenylalanine (dopa), the precursor of all the endogenous catecholamines, circulates in plasma at a concentration higher than that of the sympathetic neurotransmitter, norepinephrine (NE). Sources of dopa in plasma and the meaning of plasma dopa levels in terms of sympathoneural function have been unclear. Plasma concentrations of dopa, the catecholamines NE, epinephrine and dopamine, the deaminated catechol metabolites dihydroxyphenylglycol and dihydroxyphenylacetic acid, and the O-methylated metabolites methoxyhydroxyphenylglycol and homovanillic acid were measured during immobilization stress in conscious rats. Animals were pretreated with chlorisondamine to block ganglionic neurotransmission or with alpha-methyl-para-tyrosine to inhibit tyrosine hydroxylation. Immobilization produced rapid, sustained increases in plasma levels of dopa, catecholamines and catecholamine metabolites. Chlorisondamine decreased base-line plasma dopa and NE levels and abolished the increases in plasma dopa and NE levels during immobilization. alpha-Methyl-para-tyrosine administration produced sustained decreases in plasma dopa levels and markedly attenuated immobilization-induced increases in plasma dopa levels. Bilateral adrenalectomy augmented base-line plasma levels of dopa and NE and augmented dopa and NE responses during immobilization. The results indicate that during immobilization stress, increased postganglionic sympathoneural outflow stimulates the synthesis of dopa in sympathetic neurones and enhances release of dopa into the circulation. The data generally support the view that changes in plasma dopa levels during stress reflect in vivo changes in the rate of catecholamine biosynthesis in sympathetic nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602395

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal man.

Authors:  D S Goldstein; A Breier; O M Wolkowitz; D Pickar; J W Lenders
Journal:  Clin Auton Res       Date:  1992-12       Impact factor: 4.435

Review 2.  How does homeostasis happen? Integrative physiological, systems biological, and evolutionary perspectives.

Authors:  David S Goldstein
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-01-16       Impact factor: 3.619

3.  Catecholamines 101.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2010-07-11       Impact factor: 4.435

Review 4.  Homeostatic systems, biocybernetics, and autonomic neuroscience.

Authors:  David S Goldstein; Irwin J Kopin
Journal:  Auton Neurosci       Date:  2017-09-05       Impact factor: 3.145

Review 5.  Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky.

Authors:  David S Goldstein; Irwin J Kopin
Journal:  Cell Mol Neurobiol       Date:  2017-05-09       Impact factor: 5.046

6.  Chronic blockade of nitric oxide synthesis elevates plasma levels of catecholamines and their metabolites at rest and during stress in rats.

Authors:  R Kvetnanský; K Pacák; D Tokarev; J Jeloková; D Jezová; M Rusnák
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

7.  Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.

Authors:  David S Goldstein; Courtney Holmes; Yehonatan Sharabi
Journal:  Brain       Date:  2012-03-26       Impact factor: 13.501

8.  Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of menkes disease.

Authors:  David S Goldstein; Courtney S Holmes; Stephen G Kaler
Journal:  Neurochem Res       Date:  2009-02-21       Impact factor: 3.996

9.  Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.

Authors:  David S Goldstein; Yunden Jinsmaa; Patti Sullivan; Courtney Holmes; Irwin J Kopin; Yehonatan Sharabi
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030

10.  Renal response to amino acid infusion in rats: effect of dopamine receptor antagonists and benserazide.

Authors:  B Mühlbauer; E Hartenburg; H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.